HEADER TRANSPORT PROTEIN 04-OCT-17 6ENE TITLE OMPF ORTHOLOGUE FROM ENTEROBACTER CLOACAE (OMPE35) COMPND MOL_ID: 1; COMPND 2 MOLECULE: OUTER MEMBRANE PROTEIN (PORIN); COMPND 3 CHAIN: A, B, C; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROBACTER CLOACAE; SOURCE 3 ORGANISM_TAXID: 550; SOURCE 4 GENE: OMPF, NCTC10005_05711; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PORINE OMPF-ORTHOLOGUE, OUTER MEMBRANE, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.VAN DEN BERG,J.ABELLON-RUIZ,A.BASLE REVDAT 5 17-JAN-24 6ENE 1 HETSYN REVDAT 4 29-JUL-20 6ENE 1 COMPND REMARK HETNAM SITE REVDAT 3 13-NOV-19 6ENE 1 JRNL REVDAT 2 25-SEP-19 6ENE 1 COMPND SOURCE DBREF REVDAT 1 31-OCT-18 6ENE 0 JRNL AUTH S.ACOSTA-GUTIERREZ,L.FERRARA,M.PATHANIA,M.MASI,J.WANG, JRNL AUTH 2 I.BODRENKO,M.ZAHN,M.WINTERHALTER,R.A.STAVENGER,J.M.PAGES, JRNL AUTH 3 J.H.NAISMITH,B.VAN DEN BERG,M.G.P.PAGE,M.CECCARELLI JRNL TITL GETTING DRUGS INTO GRAM-NEGATIVE BACTERIA: RATIONAL RULES JRNL TITL 2 FOR PERMEATION THROUGH GENERAL PORINS. JRNL REF ACS INFECT DIS. V. 4 1487 2018 JRNL REFN ESSN 2373-8227 JRNL PMID 29962203 JRNL DOI 10.1021/ACSINFECDIS.8B00108 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.84 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 70510 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.208 REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.150 REMARK 3 FREE R VALUE TEST SET COUNT : 3630 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.8440 - 6.8066 0.99 2720 147 0.2203 0.2375 REMARK 3 2 6.8066 - 5.4053 1.00 2649 147 0.1933 0.2144 REMARK 3 3 5.4053 - 4.7229 1.00 2617 134 0.1745 0.2175 REMARK 3 4 4.7229 - 4.2914 1.00 2555 174 0.1587 0.2253 REMARK 3 5 4.2914 - 3.9840 1.00 2585 155 0.1859 0.2089 REMARK 3 6 3.9840 - 3.7492 1.00 2585 124 0.1925 0.2013 REMARK 3 7 3.7492 - 3.5615 1.00 2620 128 0.1950 0.2044 REMARK 3 8 3.5615 - 3.4065 1.00 2567 144 0.1967 0.2578 REMARK 3 9 3.4065 - 3.2754 1.00 2551 148 0.2090 0.2299 REMARK 3 10 3.2754 - 3.1624 1.00 2570 152 0.2142 0.2846 REMARK 3 11 3.1624 - 3.0636 1.00 2532 138 0.2246 0.2965 REMARK 3 12 3.0636 - 2.9760 1.00 2588 126 0.2319 0.2942 REMARK 3 13 2.9760 - 2.8977 1.00 2550 156 0.2346 0.2757 REMARK 3 14 2.8977 - 2.8270 1.00 2559 126 0.2293 0.2836 REMARK 3 15 2.8270 - 2.7628 1.00 2544 148 0.2307 0.2952 REMARK 3 16 2.7628 - 2.7040 1.00 2574 129 0.2186 0.2793 REMARK 3 17 2.7040 - 2.6499 1.00 2560 150 0.2229 0.3006 REMARK 3 18 2.6499 - 2.5999 1.00 2536 125 0.2307 0.2969 REMARK 3 19 2.5999 - 2.5535 1.00 2564 143 0.2266 0.2977 REMARK 3 20 2.5535 - 2.5102 1.00 2582 123 0.2299 0.2755 REMARK 3 21 2.5102 - 2.4697 1.00 2529 144 0.2482 0.2994 REMARK 3 22 2.4697 - 2.4317 1.00 2529 133 0.2573 0.2985 REMARK 3 23 2.4317 - 2.3959 1.00 2570 150 0.2593 0.3438 REMARK 3 24 2.3959 - 2.3622 1.00 2527 135 0.2715 0.3168 REMARK 3 25 2.3622 - 2.3303 1.00 2560 117 0.2922 0.3422 REMARK 3 26 2.3303 - 2.3000 1.00 2557 134 0.2975 0.3378 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.310 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.470 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.015 8005 REMARK 3 ANGLE : 1.405 10792 REMARK 3 CHIRALITY : 0.077 1064 REMARK 3 PLANARITY : 0.008 1445 REMARK 3 DIHEDRAL : 6.236 6188 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ENE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1200006833. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-JUN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 70576 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 46.810 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.35 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2ZFG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.17 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05M CITRIC ACID 0.1M LITHIUM SULFATE REMARK 280 0.05M SODIUM PHOSPHATE DIBASIC 19% PEG 1000, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.47850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.47850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 68.77400 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 93.62650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 68.77400 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 93.62650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 61.47850 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 68.77400 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 93.62650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 61.47850 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 68.77400 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 93.62650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12860 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -103.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP B 48 O HOH B 501 1.95 REMARK 500 O4 SO4 C 401 O HOH C 501 2.08 REMARK 500 O HOH C 563 O HOH C 567 2.12 REMARK 500 OD1 ASP B 190 NZ LYS B 205 2.17 REMARK 500 O HOH C 564 O HOH C 566 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASN B 9 CB ASN B 9 CG 0.160 REMARK 500 ASN C 9 CB ASN C 9 CG 0.150 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 12 CB - CG - OD1 ANGL. DEV. = 5.8 DEGREES REMARK 500 GLN A 199 N - CA - CB ANGL. DEV. = 14.0 DEGREES REMARK 500 GLN A 199 CA - CB - CG ANGL. DEV. = 13.9 DEGREES REMARK 500 ARG B 163 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 LEU C 142 CA - CB - CG ANGL. DEV. = 17.1 DEGREES REMARK 500 LYS C 312 CA - CB - CG ANGL. DEV. = 15.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 5 95.34 -168.90 REMARK 500 ASP A 27 -47.30 91.21 REMARK 500 ALA A 79 100.61 -166.16 REMARK 500 PHE A 85 73.35 -106.09 REMARK 500 GLU A 112 -40.34 -134.44 REMARK 500 PHE A 113 -154.63 -94.67 REMARK 500 PHE A 123 -106.64 55.42 REMARK 500 ILE A 275 -40.58 -138.21 REMARK 500 GLU A 278 144.26 -174.50 REMARK 500 ASN A 282 104.27 -165.84 REMARK 500 ASN A 293 -166.39 -175.07 REMARK 500 ASN B 5 94.95 -163.82 REMARK 500 ALA B 79 102.69 -167.85 REMARK 500 PHE B 85 77.97 -106.04 REMARK 500 GLU B 112 -44.14 -136.46 REMARK 500 PHE B 113 -155.50 -93.63 REMARK 500 PHE B 123 -104.21 55.44 REMARK 500 ILE B 275 -38.74 -137.03 REMARK 500 GLU B 278 142.17 -173.83 REMARK 500 ASN B 282 106.68 -168.30 REMARK 500 ASN B 293 -167.17 -175.94 REMARK 500 ASN C 5 95.77 -164.28 REMARK 500 ALA C 79 106.42 -168.14 REMARK 500 GLU C 112 -42.12 -136.87 REMARK 500 PHE C 113 -156.13 -96.18 REMARK 500 PHE C 123 -105.28 57.64 REMARK 500 ILE C 275 -39.66 -137.60 REMARK 500 GLU C 278 143.85 -171.52 REMARK 500 ASN C 282 102.11 -166.59 REMARK 500 ASN C 293 -168.43 -173.94 REMARK 500 ASP C 310 32.88 -78.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 574 DISTANCE = 6.29 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 C8E A 404 REMARK 610 C8E A 405 REMARK 610 C8E A 406 REMARK 610 C8E A 407 REMARK 610 C8E A 408 REMARK 610 C8E C 404 DBREF1 6ENE A 1 329 UNP A0A0M7H8A9_ENTCL DBREF2 6ENE A A0A0M7H8A9 23 351 DBREF1 6ENE B 1 329 UNP A0A0M7H8A9_ENTCL DBREF2 6ENE B A0A0M7H8A9 23 351 DBREF1 6ENE C 1 329 UNP A0A0M7H8A9_ENTCL DBREF2 6ENE C A0A0M7H8A9 23 351 SEQRES 1 A 329 ALA GLU ILE TYR ASN LYS ASP GLY ASN LYS LEU ASP LEU SEQRES 2 A 329 TYR GLY LYS ALA VAL GLY LEU HIS TYR PHE SER ASP ASN SEQRES 3 A 329 ASP GLY ASN ASP GLY ASP LYS THR TYR ALA ARG LEU GLY SEQRES 4 A 329 PHE LYS GLY GLU THR LYS ILE ASN ASP GLN LEU THR GLY SEQRES 5 A 329 TYR GLY GLN TRP GLU TYR ASN PHE GLN GLY ASN ASN SER SEQRES 6 A 329 GLU GLY ALA ASP ALA GLN SER GLY ASN LYS THR ARG LEU SEQRES 7 A 329 ALA PHE ALA GLY LEU LYS PHE GLY ASP ALA GLY SER PHE SEQRES 8 A 329 ASP TYR GLY ARG ASN TYR GLY LEU VAL TYR ASP ALA ILE SEQRES 9 A 329 GLY ILE THR ASP MET LEU PRO GLU PHE GLY GLY ASP THR SEQRES 10 A 329 GLY VAL SER ASP ASN PHE PHE SER GLY ARG THR GLY GLY SEQRES 11 A 329 LEU ALA THR TYR ARG ASN SER GLY PHE PHE GLY LEU VAL SEQRES 12 A 329 ASP GLY LEU ASN PHE GLY VAL GLN TYR LEU GLY LYS ASN SEQRES 13 A 329 GLU ARG THR ASP ALA LEU ARG SER ASN GLY ASP GLY TRP SEQRES 14 A 329 ALA THR SER LEU SER TYR ASP PHE ASP GLY PHE GLY ILE SEQRES 15 A 329 VAL GLY ALA TYR GLY ALA ALA ASP ARG THR ASN ALA GLN SEQRES 16 A 329 GLN ASN LEU GLN TRP GLY LYS GLY ASP LYS ALA GLU GLN SEQRES 17 A 329 TRP ALA THR GLY LEU LYS TYR ASP ALA ASN ASN ILE TYR SEQRES 18 A 329 LEU ALA ALA LEU TYR GLY GLU MET ARG ASN ALA ALA ARG SEQRES 19 A 329 LEU ASP ASN GLY PHE ALA ASN LYS THR GLN ASP PHE SER SEQRES 20 A 329 VAL VAL ALA GLN TYR GLN PHE ASP PHE GLY LEU ARG PRO SEQRES 21 A 329 SER ILE ALA TYR TYR LYS SER LYS ALA LYS ASP VAL GLU SEQRES 22 A 329 GLY ILE GLY ASP GLU ASP TYR ILE ASN TYR ILE ASP ILE SEQRES 23 A 329 GLY ALA THR TYR TYR PHE ASN LYS ASN MET SER THR TYR SEQRES 24 A 329 VAL ASP TYR GLN ILE ASN GLN LEU LYS ASP ASP ASN LYS SEQRES 25 A 329 LEU GLY ILE ASN ASN ASP ASP THR VAL ALA VAL GLY LEU SEQRES 26 A 329 VAL TYR GLN PHE SEQRES 1 B 329 ALA GLU ILE TYR ASN LYS ASP GLY ASN LYS LEU ASP LEU SEQRES 2 B 329 TYR GLY LYS ALA VAL GLY LEU HIS TYR PHE SER ASP ASN SEQRES 3 B 329 ASP GLY ASN ASP GLY ASP LYS THR TYR ALA ARG LEU GLY SEQRES 4 B 329 PHE LYS GLY GLU THR LYS ILE ASN ASP GLN LEU THR GLY SEQRES 5 B 329 TYR GLY GLN TRP GLU TYR ASN PHE GLN GLY ASN ASN SER SEQRES 6 B 329 GLU GLY ALA ASP ALA GLN SER GLY ASN LYS THR ARG LEU SEQRES 7 B 329 ALA PHE ALA GLY LEU LYS PHE GLY ASP ALA GLY SER PHE SEQRES 8 B 329 ASP TYR GLY ARG ASN TYR GLY LEU VAL TYR ASP ALA ILE SEQRES 9 B 329 GLY ILE THR ASP MET LEU PRO GLU PHE GLY GLY ASP THR SEQRES 10 B 329 GLY VAL SER ASP ASN PHE PHE SER GLY ARG THR GLY GLY SEQRES 11 B 329 LEU ALA THR TYR ARG ASN SER GLY PHE PHE GLY LEU VAL SEQRES 12 B 329 ASP GLY LEU ASN PHE GLY VAL GLN TYR LEU GLY LYS ASN SEQRES 13 B 329 GLU ARG THR ASP ALA LEU ARG SER ASN GLY ASP GLY TRP SEQRES 14 B 329 ALA THR SER LEU SER TYR ASP PHE ASP GLY PHE GLY ILE SEQRES 15 B 329 VAL GLY ALA TYR GLY ALA ALA ASP ARG THR ASN ALA GLN SEQRES 16 B 329 GLN ASN LEU GLN TRP GLY LYS GLY ASP LYS ALA GLU GLN SEQRES 17 B 329 TRP ALA THR GLY LEU LYS TYR ASP ALA ASN ASN ILE TYR SEQRES 18 B 329 LEU ALA ALA LEU TYR GLY GLU MET ARG ASN ALA ALA ARG SEQRES 19 B 329 LEU ASP ASN GLY PHE ALA ASN LYS THR GLN ASP PHE SER SEQRES 20 B 329 VAL VAL ALA GLN TYR GLN PHE ASP PHE GLY LEU ARG PRO SEQRES 21 B 329 SER ILE ALA TYR TYR LYS SER LYS ALA LYS ASP VAL GLU SEQRES 22 B 329 GLY ILE GLY ASP GLU ASP TYR ILE ASN TYR ILE ASP ILE SEQRES 23 B 329 GLY ALA THR TYR TYR PHE ASN LYS ASN MET SER THR TYR SEQRES 24 B 329 VAL ASP TYR GLN ILE ASN GLN LEU LYS ASP ASP ASN LYS SEQRES 25 B 329 LEU GLY ILE ASN ASN ASP ASP THR VAL ALA VAL GLY LEU SEQRES 26 B 329 VAL TYR GLN PHE SEQRES 1 C 329 ALA GLU ILE TYR ASN LYS ASP GLY ASN LYS LEU ASP LEU SEQRES 2 C 329 TYR GLY LYS ALA VAL GLY LEU HIS TYR PHE SER ASP ASN SEQRES 3 C 329 ASP GLY ASN ASP GLY ASP LYS THR TYR ALA ARG LEU GLY SEQRES 4 C 329 PHE LYS GLY GLU THR LYS ILE ASN ASP GLN LEU THR GLY SEQRES 5 C 329 TYR GLY GLN TRP GLU TYR ASN PHE GLN GLY ASN ASN SER SEQRES 6 C 329 GLU GLY ALA ASP ALA GLN SER GLY ASN LYS THR ARG LEU SEQRES 7 C 329 ALA PHE ALA GLY LEU LYS PHE GLY ASP ALA GLY SER PHE SEQRES 8 C 329 ASP TYR GLY ARG ASN TYR GLY LEU VAL TYR ASP ALA ILE SEQRES 9 C 329 GLY ILE THR ASP MET LEU PRO GLU PHE GLY GLY ASP THR SEQRES 10 C 329 GLY VAL SER ASP ASN PHE PHE SER GLY ARG THR GLY GLY SEQRES 11 C 329 LEU ALA THR TYR ARG ASN SER GLY PHE PHE GLY LEU VAL SEQRES 12 C 329 ASP GLY LEU ASN PHE GLY VAL GLN TYR LEU GLY LYS ASN SEQRES 13 C 329 GLU ARG THR ASP ALA LEU ARG SER ASN GLY ASP GLY TRP SEQRES 14 C 329 ALA THR SER LEU SER TYR ASP PHE ASP GLY PHE GLY ILE SEQRES 15 C 329 VAL GLY ALA TYR GLY ALA ALA ASP ARG THR ASN ALA GLN SEQRES 16 C 329 GLN ASN LEU GLN TRP GLY LYS GLY ASP LYS ALA GLU GLN SEQRES 17 C 329 TRP ALA THR GLY LEU LYS TYR ASP ALA ASN ASN ILE TYR SEQRES 18 C 329 LEU ALA ALA LEU TYR GLY GLU MET ARG ASN ALA ALA ARG SEQRES 19 C 329 LEU ASP ASN GLY PHE ALA ASN LYS THR GLN ASP PHE SER SEQRES 20 C 329 VAL VAL ALA GLN TYR GLN PHE ASP PHE GLY LEU ARG PRO SEQRES 21 C 329 SER ILE ALA TYR TYR LYS SER LYS ALA LYS ASP VAL GLU SEQRES 22 C 329 GLY ILE GLY ASP GLU ASP TYR ILE ASN TYR ILE ASP ILE SEQRES 23 C 329 GLY ALA THR TYR TYR PHE ASN LYS ASN MET SER THR TYR SEQRES 24 C 329 VAL ASP TYR GLN ILE ASN GLN LEU LYS ASP ASP ASN LYS SEQRES 25 C 329 LEU GLY ILE ASN ASN ASP ASP THR VAL ALA VAL GLY LEU SEQRES 26 C 329 VAL TYR GLN PHE HET SO4 A 401 5 HET SO4 A 402 5 HET BOG A 403 20 HET C8E A 404 14 HET C8E A 405 10 HET C8E A 406 11 HET C8E A 407 9 HET C8E A 408 8 HET SO4 B 401 5 HET SO4 B 402 5 HET SO4 C 401 5 HET SO4 C 402 5 HET SO4 C 403 5 HET C8E C 404 7 HETNAM SO4 SULFATE ION HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM C8E (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 4 SO4 7(O4 S 2-) FORMUL 6 BOG C14 H28 O6 FORMUL 7 C8E 6(C16 H34 O5) FORMUL 18 HOH *188(H2 O) HELIX 1 AA1 GLY A 86 ALA A 88 5 3 HELIX 2 AA2 VAL A 100 GLY A 105 1 6 HELIX 3 AA3 ILE A 106 ASP A 108 5 3 HELIX 4 AA4 ASP A 160 SER A 164 5 5 HELIX 5 AA5 ASN A 193 LEU A 198 5 6 HELIX 6 AA6 ASN B 26 ASP B 30 5 5 HELIX 7 AA7 VAL B 100 GLY B 105 1 6 HELIX 8 AA8 ILE B 106 ASP B 108 5 3 HELIX 9 AA9 ASP B 160 SER B 164 5 5 HELIX 10 AB1 ASN B 193 LEU B 198 5 6 HELIX 11 AB2 VAL C 100 GLY C 105 1 6 HELIX 12 AB3 ILE C 106 ASP C 108 5 3 HELIX 13 AB4 GLY C 138 VAL C 143 1 6 HELIX 14 AB5 ASP C 160 SER C 164 5 5 HELIX 15 AB6 THR C 192 ASN C 197 1 6 SHEET 1 AA118 GLU A 2 LYS A 6 0 SHEET 2 AA118 ASN A 9 SER A 24 -1 O LEU A 11 N TYR A 4 SHEET 3 AA118 THR A 320 PHE A 329 -1 O TYR A 327 N ALA A 17 SHEET 4 AA118 MET A 296 ASN A 305 -1 N ASP A 301 O ALA A 322 SHEET 5 AA118 GLY A 276 ASN A 293 -1 N ILE A 284 O ILE A 304 SHEET 6 AA118 LEU A 258 VAL A 272 -1 N SER A 261 O GLY A 287 SHEET 7 AA118 GLY A 238 TYR A 252 -1 N GLN A 244 O LYS A 268 SHEET 8 AA118 ILE A 220 LEU A 235 -1 N TYR A 221 O GLN A 251 SHEET 9 AA118 LYS A 205 ALA A 217 -1 N GLU A 207 O ARG A 230 SHEET 10 AA118 PHE A 180 ASP A 190 -1 N ALA A 189 O ALA A 206 SHEET 11 AA118 GLY A 168 PHE A 177 -1 N TYR A 175 O ILE A 182 SHEET 12 AA118 LEU A 146 LEU A 153 -1 N LEU A 153 O GLY A 168 SHEET 13 AA118 ARG A 127 SER A 137 -1 N TYR A 134 O VAL A 150 SHEET 14 AA118 SER A 90 TYR A 97 -1 N SER A 90 O ARG A 135 SHEET 15 AA118 LYS A 75 LYS A 84 -1 N LEU A 83 O PHE A 91 SHEET 16 AA118 LEU A 50 GLN A 61 -1 N ASN A 59 O LYS A 75 SHEET 17 AA118 TYR A 35 ASN A 47 -1 N ALA A 36 O PHE A 60 SHEET 18 AA118 ASN A 9 SER A 24 -1 N VAL A 18 O TYR A 35 SHEET 1 AA219 GLU B 2 LYS B 6 0 SHEET 2 AA219 GLY B 31 ASP B 32 0 SHEET 3 AA219 TYR B 35 ASN B 47 0 SHEET 4 AA219 LEU B 50 GLN B 61 -1 O GLY B 52 N THR B 44 SHEET 5 AA219 LYS B 75 LYS B 84 -1 O LYS B 84 N THR B 51 SHEET 6 AA219 SER B 90 TYR B 97 -1 O ARG B 95 N ALA B 79 SHEET 7 AA219 ARG B 127 SER B 137 -1 O LEU B 131 N GLY B 94 SHEET 8 AA219 LEU B 146 LEU B 153 -1 O TYR B 152 N ALA B 132 SHEET 9 AA219 GLY B 168 PHE B 177 -1 O GLY B 168 N LEU B 153 SHEET 10 AA219 PHE B 180 ASP B 190 -1 O PHE B 180 N PHE B 177 SHEET 11 AA219 LYS B 205 ALA B 217 -1 O ALA B 206 N ALA B 189 SHEET 12 AA219 ILE B 220 LEU B 235 -1 O LEU B 222 N TYR B 215 SHEET 13 AA219 GLY B 238 TYR B 252 -1 O ASP B 245 N GLY B 227 SHEET 14 AA219 LEU B 258 VAL B 272 -1 O LYS B 270 N LYS B 242 SHEET 15 AA219 GLY B 276 ASN B 293 -1 O GLU B 278 N ALA B 269 SHEET 16 AA219 MET B 296 ASN B 305 -1 O ILE B 304 N ILE B 284 SHEET 17 AA219 THR B 320 PHE B 329 -1 O THR B 320 N GLN B 303 SHEET 18 AA219 ASN B 9 PHE B 23 -1 N ALA B 17 O TYR B 327 SHEET 19 AA219 GLY B 31 ASP B 32 -1 O GLY B 31 N TYR B 22 SHEET 1 AA319 GLU C 2 LYS C 6 0 SHEET 2 AA319 GLY C 31 ASP C 32 0 SHEET 3 AA319 TYR C 35 ASN C 47 0 SHEET 4 AA319 LEU C 50 GLN C 61 -1 O PHE C 60 N ALA C 36 SHEET 5 AA319 LYS C 75 PHE C 85 -1 O LYS C 84 N THR C 51 SHEET 6 AA319 SER C 90 TYR C 97 -1 O ARG C 95 N ALA C 79 SHEET 7 AA319 ARG C 127 SER C 137 -1 O THR C 133 N ASP C 92 SHEET 8 AA319 LEU C 146 LEU C 153 -1 O TYR C 152 N ALA C 132 SHEET 9 AA319 GLY C 168 PHE C 177 -1 O SER C 174 N ASN C 147 SHEET 10 AA319 PHE C 180 ASP C 190 -1 O GLY C 184 N LEU C 173 SHEET 11 AA319 LYS C 205 ALA C 217 -1 O ALA C 206 N ALA C 189 SHEET 12 AA319 ILE C 220 ARG C 230 -1 O TYR C 226 N THR C 211 SHEET 13 AA319 LYS C 242 TYR C 252 -1 O SER C 247 N LEU C 225 SHEET 14 AA319 LEU C 258 VAL C 272 -1 O LYS C 268 N GLN C 244 SHEET 15 AA319 GLY C 276 ASN C 293 -1 O GLU C 278 N ALA C 269 SHEET 16 AA319 MET C 296 ASN C 305 -1 O ILE C 304 N ILE C 284 SHEET 17 AA319 THR C 320 PHE C 329 -1 O ALA C 322 N ASP C 301 SHEET 18 AA319 ASN C 9 PHE C 23 -1 N ALA C 17 O TYR C 327 SHEET 19 AA319 GLY C 31 ASP C 32 -1 O GLY C 31 N TYR C 22 SHEET 1 AA4 2 ARG C 234 LEU C 235 0 SHEET 2 AA4 2 GLY C 238 PHE C 239 -1 O GLY C 238 N LEU C 235 CRYST1 137.548 187.253 122.957 90.00 90.00 90.00 C 2 2 21 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007270 0.000000 0.000000 0.00000 SCALE2 0.000000 0.005340 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008133 0.00000